Zurcher Kantonalbank (Zurich Cantonalbank) Intellia Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 26,905 shares of NTLA stock, worth $381,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,905

Previous 26,905 -0.0%

Holding current value

$381,243

Previous $552,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$19.72 - $27.36 $13,449 - $18,659	-682 Reduced 2.47%	26,905 $552,000
Q2 2024 Jul 29, 2024	BUY	$20.02 - $27.22 $96,576 - $131,309	4,824 Added 21.19%	27,587 $617,000
Q1 2024 Apr 25, 2024	SELL	$23.82 - $32.8 $14,816 - $20,401	-622 Reduced 2.66%	22,763 $626,000
Q4 2023 Jan 30, 2024	BUY	$23.16 - $32.34 $14,984 - $20,923	647 Added 2.85%	23,385 $713,000
Q3 2023 Oct 25, 2023	BUY	$31.62 - $45.78 $83,982 - $121,591	2,656 Added 13.23%	22,738 $718,000
Q2 2023 Aug 07, 2023	BUY	$34.58 - $46.03 $66,843 - $88,975	1,933 Added 10.65%	20,082 $818,000
Q1 2023 May 08, 2023	BUY	$33.3 - $44.82 $44,255 - $59,565	1,329 Added 7.9%	18,149 $676,000
Q4 2022 Feb 01, 2023	BUY	$33.21 - $62.69 $34,638 - $65,385	1,043 Added 6.61%	16,820 $586,000
Q3 2022 Nov 09, 2022	BUY	$53.92 - $71.7 $13,318 - $17,709	247 Added 1.59%	15,777 $883,000
Q2 2022 Aug 09, 2022	SELL	$38.49 - $76.21 $27,828 - $55,099	-723 Reduced 4.45%	15,530 $804,000
Q1 2022 Apr 21, 2022	BUY	$58.27 - $118.99 $10,138 - $20,704	174 Added 1.08%	16,253 $1.18 Million
Q4 2021 Feb 01, 2022	BUY	$100.76 - $138.36 $244,242 - $335,384	2,424 Added 17.75%	16,079 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $110,131 - $147,080	832 Added 6.49%	13,655 $1.83 Million
Q2 2021 Jul 30, 2021	BUY	$60.88 - $161.91 $78,109 - $207,730	1,283 Added 11.12%	12,823 $2.08 Million
Q1 2021 May 03, 2021	BUY	$46.59 - $83.68 $248,650 - $446,600	5,337 Added 86.04%	11,540 $926,000
Q4 2020 Jan 28, 2021	BUY	$18.83 - $63.53 $14,649 - $49,426	778 Added 14.34%	6,203 $337,000
Q2 2020 Jul 28, 2020	BUY	$11.14 - $22.87 $25,610 - $52,578	2,299 Added 73.54%	5,425 $114,000
Q1 2020 May 06, 2020	BUY	$9.44 - $15.58 $13,499 - $22,279	1,430 Added 84.32%	3,126 $38,000
Q3 2019 Oct 18, 2019	BUY	$13.07 - $18.51 $5,737 - $8,125	439 Added 34.92%	1,696 $23,000
Q1 2019 Apr 29, 2019	SELL	$12.79 - $17.62 $57,248 - $78,867	-4,476 Reduced 78.07%	1,257 $21,000
Q2 2018 Aug 06, 2018	BUY	$20.02 - $30.79 $96,236 - $148,007	4,807 Added 519.11%	5,733 $157,000
Q4 2017 Jan 31, 2018	BUY	$17.39 - $31.12 $16,103 - $28,817	926	926 $18,000

Others Institutions Holding NTLA

# of Institutions

312

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.08B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Intellia Therapeutics, Inc. Transaction History